Korean J Obstet Gynecol.  1998 Jul;41(7):1896-1900.

A Study on the Expression of Bad Gene during the Corpus Luteum Regression of Rat

Abstract

Much progress has been made in recent years towards a greater understanding of the complex series of apoptotic events and suggested that the degeneration of ovarian corpus luteum is apoptotic cell death. Recent reports have demonstrated that PGF2alpha induces generation of reactive oxygen species or their intermediates inhibits progesterone synthesis and may also serve as a trigger for apoptosis in the corpus luteum. So we have preliminarily characterized changes in the expression of the bad gene in corpus luteum. DNA fragments corresponding to bad coding sequence were cloned from rat ovary for this study. Also RNase protection assay (RPA) and 4, 6, -diamidino-2-phenylindole (DAPI) staining analysis were used to check the steady-state bad mRNA levels in total RNA and apoptotic assay of histological sections prepared from corpus luteum. We have found that the rate of apoptotic cells was increased during the progress of corpus luteum life cycle at hCG induced or pregnant rat. Also PGF2alpha treatment increased the expression of bad gene in corpus luteum. This indicates that corpus luteum regression may accelerate apoptosis by a direct or indirect induction of the bad gene expressions. These data first reveal that PGF2alpha plays an important roles via bad gene expression in the regulation of rat corpus luteum regression.

Keyword

Apoptosis; Bad gene; Corpus luteum; PGF2alpha

MeSH Terms

Animals
Apoptosis
Cell Death
Clinical Coding
Clone Cells
Corpus Luteum*
Dinoprost
DNA
Female
Gene Expression
Life Cycle Stages
Luteolysis*
Ovary
Progesterone
Rats*
Reactive Oxygen Species
Ribonucleases
RNA
RNA, Messenger
DNA
Dinoprost
Progesterone
RNA
RNA, Messenger
Reactive Oxygen Species
Ribonucleases
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr